-->

Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.40
Shares Outstanding179.1M
Average Volume (10 days)1.4M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.50)
Sales (TTM)$8.35
Book Value (MRQ)$16.40
Cash Flow (TTM)$0.04
Cash (MRQ)$5.02

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy14
 
Buy1
 
Hold3
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Jean-Jacques Bienaime
Director, Chief Executive Officer
(4,000)
Sell
Apr 12, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(2,200)
Sell
Apr 8, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(100)
Sell
Apr 8, 2019
Jean-Jacques Bienaime
Director, Chief Executive Officer
(700)
Sell
Apr 8, 2019
Brian Mueller
SVP, Corporate Controller
(2,953)
Sell
Apr 5, 2019

Recent SEC Filings

Insider Buy/Sell
May 14, 2019
Insider Buy/Sell
May 13, 2019
Insider Buy/Sell
May 9, 2019
Insider Buy/Sell
Apr 30, 2019
Quarterly Financials
Apr 29, 2019

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information